Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Products In Brief

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific’s next-generation Promus Element Plus drug-eluting stent; Biotronik’s first-of-its-kind MRI-safe ICD; BSD Medical’s BSD-2000 cervical cancer treatment. More new products.

You may also be interested in...



Blood-Collection Groups Must Test Blood For Chagas Disease Parasite, US FDA Says

Donated blood must be tested by blood-collection groups for evidence of infection with Trypanosoma cruzi, a parasite that causes Chagas disease – either for donation purposes or for use in manufacturing a medical device – FDA says in final guidance released Dec. 5.

New Products In Brief

Recent launches and approvals include overseas debuts of Abbott’s Absorb bioabsorbable vascular scaffold and Medtronic’s next-generation CoreValve Evolut transcatheter aortic heart valve.

New Competition, Procedure Declines Challenge Abbott Vascular In Second Quarter

Abbott’s stent business was up against an approximately 5% decline in U.S. percutaneous coronary intervention procedures in the past quarter, on top of persistent pricing pressures and the U.S. launch earlier this year of Medtronic’s Resolute Integrity.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT030767

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel